Cargando…

Identifying therapeutic targets for schizophrenia

There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...

Descripción completa

Detalles Bibliográficos
Autor principal: Montague-Cardoso, Karli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192517/
https://www.ncbi.nlm.nih.gov/pubmed/34112930
http://dx.doi.org/10.1038/s42003-021-02270-3